| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0006 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |